Holen Sie sich die Stockscreener-App
0.612
2.17%
-0.0136
Schlusskurs vom Vortag:
$0.6256
Offen:
$0.606
24-Stunden-Volumen:
39,957
Relative Volume:
0.02
Marktkapitalisierung:
$3.16M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.28M
KGV:
-0.0133
EPS:
-45.9343
Netto-Cashflow:
$-7.99M
1W Leistung:
+0.82%
1M Leistung:
-29.22%
6M Leistung:
-18.41%
1J Leistung:
-85.57%
1-Tages-Spanne:
$0.606
$0.65
1-Wochen-Bereich:
$0.5698
$0.68
52-Wochen-Spanne:
$0.4772
$6.18
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Company Profile
Firmenname
Quoin Pharmaceuticals Ltd Adr
Sektor
Branche
Telefon
97299741444
Adresse
23 HATA'AS STREET, KFAR SABA
Vergleichen Sie QNRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| QNRX | 0.612 | 3.16M | 0 | -8.28M | -7.99M | -45.93 |
| VRTX | 449.93 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 746.15 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 595.77 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.03 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.17 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Quoin Pharmaceuticals Ltd Adr Aktie (QNRX) Neueste Nachrichten
Quoin Pharmaceuticals advances Netherton syndrome treatment trial - Investing.com
Quoin Pharmaceuticals granted extension to meet Nasdaq listing - Investing.com India
Quoin Pharmaceuticals granted extension to meet Nasdaq listing By Investing.com - Investing.com UK
Quoin Pharmaceuticals expands UK clinical trials for rare disease - Investing.com
Quoin Pharmaceuticals sets date for 2024 shareholder meeting - Investing.com
Balance Sheet Insights: Quoin Pharmaceuticals Ltd ADR (QNRX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Quoin Pharmaceuticals CFO buys shares worth over $23,000 - Investing.com
Healthy Upside Potential: Quoin Pharmaceuticals Ltd ADR (QNRX) - SETE News
A closer look at QNRX’s price-to-free cash flow ratio - US Post News
Quoin Pharmaceuticals COO acquires $28,737 in company shares - Investing.com
Quoin Pharmaceuticals CEO acquires shares worth over $28k - Investing.com
Quoin Pharmaceuticals (NASDAQ:QNRX) Stock Quotes, Forecast and News Summary - Benzinga
QNRX Stock Hits 52-Week Low at $0.57 Amid Market Challenges - Investing.com Australia
Quoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National Conference - GlobeNewswire Inc.
Quoin Pharmaceuticals partners with UCC for drug delivery tech By Investing.com - Investing.com
Quoin Pharmaceuticals director Dennis Langer sells shares worth $217 - Investing.com India
Quoin Pharmaceuticals director Dennis Langer sells shares worth $217 By Investing.com - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
GLMD Stock Quote Price and Forecast - CNN
U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.04% - Investing.com India
Major Indexes Muted Following Strong Jobs Report - Schaeffers Research
Quoin Pharmaceuticals (QNRX) Stock Price, News & Analysis - MarketBeat
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
Finanzdaten der Quoin Pharmaceuticals Ltd Adr-Aktie (QNRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):